Australian Pharmaceutical Industries Ltd (ASX:API) is the pharmacy company behind Priceline, ClearSkincare, Soul Pattinson Chemist and much more. The Melbourne-based company is more than 100 years old and operates more than 500 chemists and hundreds more are included in its member network. API is part-owned by Washington H. Soul Pattinson (ASX: SOL).
The Wesfarmers Ltd (ASX:WES) share price will be on watch this morning after making a bid for Australian Pharmaceutical Industries Ltd (ASX:API).
The Australian Pharmaceutical Industries Ltd (ASX:API) share price is down over 2% after reporting its FY21 half-year result.
Washington H. Soul Pattinson and Co. Ltd (ASX:SOL) could be the best ASX dividend share, and I’m going to tell you why.
Could the Australian Pharmaceutical Industries Ltd (ASX:API) share price be worthwhile considering as a turnaround play?
Australian Pharmaceutical Industries Ltd (ASX:API) has reported its FY20 result, which included a heavy profit decline.
Robert Milner of Washington H. Soul Pattinson & Co. Ltd (ASX:SOL) and Brickworks Ltd (ASX:BKW) took some time to sit down for The Australian Investors Podcast and talk about life, being one of Australia’s most business leaders and, of course, his investment process.
The API (ASX:API) share price will be on watch today after the company welcome increased government funding.
The Australian Pharmaceutical Industries (ASX:API) share price has fallen 8% in response to the company’s FY20 half year result.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.52% at lunch.
